Association of HIV infection with anal and penile low-risk human papillomavirus infections among men who have sex with men in Amsterdam: The HIV & HPV in MSM study

Sexually Transmitted Diseases

Volumn 42, Issue 6, 2015, Pages 297-304

  Welling, Camiel A H ^a   Mooij, Sofie H ^a,b   Van Der Sande, Marianne A B ^c,d   Van Rooijen, Martijn S ^a   Vermeulen Oost, Wilma F ^a   King, Audrey J ^c   Van Eeden, Arne ^e,g   Heideman, Daniëlle A M ^f   Stolte, Ineke G ^a,b   Van Der Loeff, Maarten F Schim ^a,b  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e Jan Van Goyen Medical Center   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g HIV Focus Center DC Klinieken Oud Zuid   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAL INTERCOURSE; ANILINGUS; ARTICLE; CANNABIS USE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 34; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 43; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 74; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT INFECTION; MEN WHO HAVE SEX WITH MEN; MIDDLE AGED; NETHERLANDS; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION SYSTEM; PREVALENCE; QUESTIONNAIRE; SMOKING; UNSAFE SEX; WART VIRUS; ANAL CANAL; ANUS DISEASES; HIV INFECTIONS; IMMUNOLOGY; MALE HOMOSEXUALITY; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PENILE DISEASES; PENIS; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; VIROLOGY;

ADULT; ANAL CANAL; ANUS DISEASES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PENILE DISEASES; PENIS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84929851144     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000278     Document Type: Article

References (30)

1. Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics 2009; 12:291-307.
2. Bosch FX, Broker TR, Forman D, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013; 31(suppl 7):H1-H31.
3. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens- Part B: Biological agents. Lancet Oncol 2009; 10:321-322.
4. Hartwig S, Syrjanen S, Dominiak-Felden G, et al. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: A review. BMC Cancer 2012; 12:30.
5. Woodhall SC, JitM, Soldan K, et al. The impact of genitalwarts: Loss of quality of life and cost of treatment in eight sexual health clinics in the UK. Sex Transm Infect 2011; 87:458-463.
6. Giuliano AR, Tortolero-Luna G, Ferrer E, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008; 26(suppl 10):K17-K28.
7. Raymakers AJ, SadatsafaviM,Marra F, et al. Economic and humanistic burden of external genital warts. Pharmacoeconomics 2012; 30:1-16.
8. Hu D, Goldie S. The economic burden of noncervical human papillomavirus disease in the United States. Am J Obstet Gynecol 2008; 198: 500-507.
9. Firnhaber C, Sello M, Maskew M, et al. Human papillomavirus types in HIV seropositive men with penile warts in Johannesburg, South Africa. Int J STD AIDS 2011; 22:107-109.
10. Sung JH, Ahn EJ, Oh HK, et al. Association of immune status with recurrent anal condylomata in human immunodeficiency virus-positive patients. J Korean Soc Coloproctol 2012; 28:294-298.
11. de Panfilis G, Melzani G, Mori G, et al. Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls. Sex Transm Dis 2002; 29:121-125.
12. Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177:361-367.
13. Vajdic CM, Van Leeuwen MT, Jin F, et al. Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm Infect 2009; 85:330-335.
14. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis. Lancet Oncol 2012; 13:487-500.
15. Phanuphak N, Teeratakulpisarn N, Pankam T, et al. Anal human papillomavirus infection among Thai men who have sex with men with and withoutHIV infection: prevalence, incidence, and persistence. JAcquir Immune Defic Syndr 2013; 63:472-479.
16. Hu Y, Qian HZ, Sun J, et al. Anal human papillomavirus infection among HIV-infected and uninfected men who have sex with men in Beijing, China. J Acquir Immune Defic Syndr 2013; 64:103-114.
17. Wiley DJ, Li X, Hsu H, et al. Factors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM). PLoS One 2013; 8:e79492.
18. Zhang DY, Yin YP, Feng TJ, et al. HPV Infections among MSM in Shenzhen, China. PLoS One 2014; 9:e96364.
19. Dunne EF, Nielson CM, Stone KM, et al. Prevalence of HPVinfection among men: A systematic review of the literature. J Infect Dis 2006; 194:1044-1057.
20. Nyitray AG, da Silva RJ, Baggio ML, et al. The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: The HIM study. Sex Transm Dis 2011; 38:932-940.
21. Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012; 30(Suppl 5): F123-F138.
22. Van Aar F, Mooij SH, van der Sande MA, et al. Anal and penile highrisk human papillomavirus prevalence in HIV-negative and HIVinfected MSM. AIDS 2013; 27:2921-2931.
23. Jansen IA, Geskus RB, Davidovich U, et al. Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: A 25-year prospective cohort study. AIDS 2011; 25:493-501.
24. Urbanus AT, Van De Laar TJ, Geskus R, et al. Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010. AIDS 2013; 28:781-790.
25. Bezemer D, de Wolf F, Boerlijst MC, et al. 27 years of the HIV epidemic amongst men having sex with men in the Netherlands: An in depth mathematical model-based analysis. Epidemics 2010; 2:66-79.
26. Mooij SH, Boot HJ, Speksnijder AG, et al. Oral human papillomavirus infection in HIV-negative and HIV-infected men who have sex with men: The HIV & HPV in MSM (H2M) study. AIDS 2013; 27: 2117-2128.
27. Molijn A, Kleter B, QuintW, et al.Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005; 32(suppl 1):S43-S51.
28. Xue X, Gange SJ, Zhong Y, et al. Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev 2010; 19:159-169.
29. Darwich L, Canadas MP, Videla S, et al. Prevalence, clearance, and incidence of human papillomavirus type-specific infection at the anal and penile site of HIV-infected men. Sex TransmDis 2013; 40:611-618.
30. van der Snoek EM, Niesters HG, Mulder PG, et al. Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis 2003; 30:639-644.